Results 31 to 40 of about 1,671,061 (305)
Immune Checkpoint Inhibitors and Kidney Toxicity: Advances in Diagnosis and Management
Immune checkpoint inhibitors are now approved for more than 50 indications, and increasing numbers of patients with advanced cancer are receiving immunotherapy.
Harish Seethapathy +2 more
doaj +1 more source
Immune checkpoint inhibitors are increasingly drawing much attention in the therapeutic development for cancer treatment. However, many cancer patients do not respond to treatments with immune checkpoint inhibitors, partly because of the lack of tumor ...
Jennifer Kleponis +2 more
doaj +1 more source
Cancer therapeutic implications of microRNAs in the regulation of immune checkpoint blockade [PDF]
Dampening of patients’ immune response to tumor-specific antigens is a major reason for tumor development and progression. Within tumor microenvironment, aberrant expression of immune checkpoints changes T lymphocyte activity, and induces immune ...
Yan Zhang +2 more
doaj +1 more source
Esophagitis dissecans superficialis with immune checkpoint inhibitor therapy
Immune checkpoint inhibitors represent an important advance in cancer treatment, but immune mediated adverse events associated with their use can be severe and life-threatening.
Alexis Coolidge +3 more
doaj +1 more source
Treatment of melanomas with targeted and immunotherapies has proven effective, but resistance to both treatments is a common outcome leaving a high proportion of patients without effective alternative treatment options.
Helen Rizos +15 more
core +1 more source
Bub3p facilitates spindle checkpoint silencing in fission yeast [PDF]
Although critical for spindle checkpoint signaling, the role kinetochores play in anaphase promoting complex (APC) inhibition remains unclear. Here we show that spindle checkpoint proteins are severely depleted from unattached kinetochores in fission ...
Hardwick, Kevin G. +13 more
core +1 more source
Non-small cell lung cancer (NSCLC) remains the predominant subtype of lung cancer and a leading cause of cancer-related mortality worldwide. Therapeutic failure is largely driven by intratumoral heterogeneity, dynamic tumor microenvironmental stresses ...
Fuyao Shang +18 more
doaj +1 more source
Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma
With the understanding of the complex interaction between the tumour microenvironment and immunotherapy, there is increasing interest in the role of immune regulators in the treatment of head and neck squamous cell carcinoma (HNSCC).
Junwen Huang +7 more
core +1 more source
Radiation therapy is a primary treatment for hepatocellular carcinoma (HCC), but its effectiveness can be diminished by various factors. The over-expression of PD-L1 has been identified as a critical reason for radiotherapy resistance.
Tiesuo Zhao +19 more
doaj +1 more source
Pneumonitis and multiple pneumonial infections under combined immune‐checkpoint inhibition
The introduction of immune checkpoint inhibitors and targeted therapies has revolutionized melanoma treatment. The downside are immune‐mediated adverse events which are frequent and require close patient management.
Kristine E. Mayer +4 more
doaj +1 more source

